Morgan Stanley
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) Unlikely to See Success in Alzheimer Study - Morgan Stanley
-
-
-
-
-
-
-
Biohaven Announces Closing Of $144M Public Offering Of Common Shares, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $38 at Morgan Stanley
-
-
-
-
-
-
158,371 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All